The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Do More.: The U.S. Department of Health and Human Services (HHS) Pan Respiratory Virus (PRV) Public Education Campaign (PEC), Risk Less. Do More. seeks to inform the public about influenza (flu), ...

In the U.S., wastewater surveillance for public health became vital during the COVID-19 pandemic, when the U.S. Centers for Disease Control and ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Here's what experts say about using antibiotics to treat the common cold — and why you can still catch one in the summer.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Canada reports its first presumptive human H5 bird flu case ... marking the first mRNA-based authorized vaccine for ...

A Winnipeg mother with a newborn is pleading with the province to start offering RSV shots to all babies. As we navigate ...